ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.19%
      US Tech 100
      19,178.40
      -0.65%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      66,003.97
      -2.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. OSE Immunotherapeutics (OSE) Quote

      OSE Immunotherapeutics

      OSE Immunotherapeutics (OSE)

      EU
      6.44
      -0.02
      (-0.31%)
      Closed July 23 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      6.44
      Bid
      6.43
      Ask
      6.50
      Volume
      30,520
      6.44 Day's Range 6.59
      2.705 52 Week Range 8.63
      Market Cap
      140.184M
      Previous Close
      6.46
      Open
      6.54
      Last Trade
      16
      @
      6.44
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      199,336
      Shares Outstanding
      21,767,777
      Dividend Yield
      -
      PE Ratio
      -6.09
      Earnings Per Share (EPS)
      -1.06
      Revenue
      2.23M
      Net Profit
      -23M

      About OSE Immunotherapeutics

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Coml Physical, Biologcl Resh
      Website
      www.ose-immuno.com
      Headquarters
      Nantes, Loire-atlantique, Fra
      Founded
      1970
      OSE Immunotherapeutics is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker OSE. The last closing price for OSE Immunotherapeutics was 6.46 €. Over the last year, OSE Immunotherapeutics shares have traded in a share price range of 2.705 € to 8.63 €.

      OSE Immunotherapeutics currently has 21,767,777 shares outstanding. The market capitalization of OSE Immunotherapeutics is 140.62 € million. OSE Immunotherapeutics has a price to earnings ratio (PE ratio) of -6.09.

      OSE Latest News

      More News

      Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371

      Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371 Boehringer Ingelheim and OSE Immunotherapeutics...

      July 03 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancer

      OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancer OSE Immunotherapeutics et...

      July 03 2024
      GlobeNewswire Inc.

      Informations relatives au nombre total de droits de vote et d’actions composant le capital

      Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes...

      July 02 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ 

      OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’  OSE Immunotherapeutics...

      July 01 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies

      OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies NANTES, France, June 24, 2024 – 7:30am CET - OSE Immunotherapeutics SA (ISIN:...

      June 24 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics annonce un accord commercial et de partage de revenus dans le domaine des thérapies par cellules CAR-T

      OSE Immunotherapeutics annonce un accord commercial et de partage de revenus dans le domaine des thérapies par cellules CAR-T OSE Immunotherapeutics annonce un accord commercial et de partage...

      June 24 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)

      OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San...

      June 20 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics présente les résultats de l’Assemblée générale 2024 et l’évolution du Conseil d’administration prêt à conduire la stratégie de croissance de la Société

      OSE Immunotherapeutics présente les résultats de l’Assemblée générale 2024 et l’évolution du Conseil d’administration prêt à conduire la stratégie de croissance de la Société OSE...

      June 19 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse

      OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse OSE Immunotherapeutics...

      June 12 2024
      GlobeNewswire Inc.

      OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant

      OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant OSE Immunotherapeutics and Nantes University...

      June 05 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.55-7.868383404866.996.996.44966106.59436766DE
      40.416.799336650086.037.275.371396296.42787254DE
      120.8815.82733812955.568.635.371993366.95483247DE
      262.6569.92084432723.798.633.1151645886.07098283DE
      522.9986.66666666673.458.632.7051845115.36525132DE
      156-2.36-26.81818181828.813.682.705920086.20026236DE
      2602.6971.73333333333.7515.82.705849487.20145534DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALLRAllarity Therapeutics Inc
      $ 0.32
      (92.19%)
      		36.93M
      NIVFNewGenIvf Group Ltd
      $ 1.44
      (65.35%)
      		3.81M
      NUZENuZee Inc
      $ 1.50
      (45.63%)
      		237.83k
      SLNASelina Hospitality PLC
      $ 0.03165
      (21.73%)
      		38.9M
      DRMADermata Therapeutics Inc
      $ 1.53
      (17.69%)
      		94.33k
      VSTMVerastem Inc
      $ 2.74
      (-23.68%)
      		376.59k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.17
      (-16.86%)
      		207.47k
      MINMMinim Inc
      $ 2.43
      (-14.74%)
      		18.39k
      ALPPAlpine 4 Holdings Inc
      $ 0.512
      (-14.65%)
      		292.67k
      CJETChijet Motor Company Inc
      $ 4.35
      (-14.37%)
      		88.64k
      SLNASelina Hospitality PLC
      $ 0.03165
      (21.73%)
      		38.9M
      ALLRAllarity Therapeutics Inc
      $ 0.32
      (92.19%)
      		36.93M
      TSLATesla Inc
      $ 234.80
      (-4.70%)
      		12.35M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.4297
      (-9.27%)
      		10.49M
      HOLOMicroCloud Hologram Inc
      $ 0.595
      (1.74%)
      		8.57M

      Discussion

      View Full Feed
      MrAce MrAce 3 minutes ago
      .20 by Friday??
      KBLB
      Going_4_It Going_4_It 3 minutes ago
      NuScale bid on building Ghana's first nuclear reactor.

      "Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector."

      Article from July 16:

      https://oilprice.com/Alternative-Energy/Nuclear-Power/Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector.htm
      SMR
      bgoat bgoat 3 minutes ago
      Hey Jazz, I hope they do! That will bring more attention to how massive this is!!! tick tick tick ...BOOM!!
      SPZI
      chuck4345 chuck4345 3 minutes ago
      Not in our lifetime
      SHIBUSD
      blackhawks blackhawks 3 minutes ago
      Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

      J.D do your Emily Litella: The VP slot?! Oh, that's very differe
      blackhawks blackhawks 3 minutes ago
      Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

      J.D do your Emily Litella: The VP slot?! Oh, that's very differe
      MRJ25 MRJ25 4 minutes ago
      If...after a jury has condemned the FHFA for the third amendment (in the case of fannie pfd's, with interest since it was signed), it would be very strange if the third amendment continued to be valid.

      Yes, I am not a lawyer, but some other people here have mentioned that if this ruli
      FNMA
      ergo sum ergo sum 4 minutes ago
      Suddenly the whole country things the NYT was right in the first place.
      madras50 madras50 4 minutes ago
      So is there any similarity in their story?
      SLNA
      theorysuit theorysuit 5 minutes ago
      Dude you are paranoid beyond belief. Nothing you say or i say means anything. Ultimately the company must execute, and it sure doesn't look like they can. The focus has always been on LP and her enrichment.
      NWBO
      ksquared ksquared 6 minutes ago
      Kamala Harris Supporters Fear Democrat Women Losing Elections Causes PTSD
      (Oh, puh-leeze...)
      AMY FURR 23 Jul 2024 2:22 Some social media users who commented on the Occupy Democrats post did not appear to be on board with a possible Harris presidency... “No one voted f
      weedisgreen weedisgreen 6 minutes ago
      I think it will pop up to that when they announce uplisting and then come down with a slow rise back up. Back in the spring a watched a podcast at some event that talked to a tune of the institutional investors already doing their homework. I'm also feeling confident that Kim already has been gett
      TCNNF
      capgain capgain 7 minutes ago
      Could very well be. It wouldn't surprise me any, and we'll probably never know.
      Jaxxm Jaxxm 7 minutes ago
      Maybe tomorrow 1 dollar plus
      HOLO
      CaptBeer CaptBeer 7 minutes ago
      $AMRN Here’s a fun Bonus Graphic showing the first 10-month Launch of VASCEPA® (USA) vs. VAZKEPA® (UK). VASCEPA® Launched in the USA in January 2013 and VAZKEPA® launched in October 2022.
      For comparison purposes, consider:

      1. Potential Patient Populations.
      AMRN
      thistraderknowsall thistraderknowsall 8 minutes ago
      #1 MOMO BREAKOUT..ASM Altcoin to $1 online in a few minutes !!! We win!! Congrats!!!
      ASM
      Lone Clone Lone Clone 9 minutes ago
      ARK, OGC, SNAG, ODV, TUO

      Kazakhstan explorer Arras Minerals aka ARK announced the initiation of an airborne geophysical survey across its Maisor and Aktasty properties, which cover 1397 sq km and are part of the Exploration Alliance with Teck. They surround the large operating Bozshak
      TUD
      HyGro HyGro 9 minutes ago
      Except for the 8 peer reviewed articles that challenge the legitimacy of the clinical trial revisions done 2 weeks before the completion of the trial.

      Totally new comparator (one required to be approve BEFORE the trial started), change the protocol, endpoints, and experimental design
      NWBO
      devil dog 96 devil dog 96 9 minutes ago
      This is all lies. 😆 I have never seen so many lies in one post 🤡 LMAO

      " I’ve not ever bought this pig, ,not as pos tron.
      Not as pos atmh.
      Nor would I ever.
      Only a freakin moron would.imo "

      The no proof scam theory promo is a total sh
      ATMH
      Hercules1 Hercules1 9 minutes ago
      What happened to water chaser?


      Let me take a guess:

      He is covered in shit.

      From shitting all over himself.
      HIRU
      shigtynodigty shigtynodigty 10 minutes ago
      I am hoping that reverse split doesn’t happen in 2 years and they can get over the 1.00 price
      CHUC
      FACT-MASTER FACT-MASTER 10 minutes ago
      BLX: AH Price/Volume on FIRE!!

      Last at $35.05 / 31,000 shares traded AH. ( at the moment)

      https://www.nasdaq.com/market-activity/stocks/blx/after-hours
      BLX
      shigtynodigty shigtynodigty 10 minutes ago
      Big time
      CHUC
      jazz5201 jazz5201 11 minutes ago
      Bashers are going to be working overtime tonight to twist and turn things.

      This is just the beginning.

      Pennies soon...
      SPZI

      Your Recent History

      EU
      OSE
      OSE Immunotherapeutics
      MRTX
      EVNBTC
      EvenCoin
      BIT
      F06349
      Vontobel Financial Produ...
      COIN
      OUCHIETH
      OUCHI Token
      LSE
      60SZ
      Eika Boli 24
      USOTC
      BONL
      Bonal (PK)
      TSXV
      NFR
      Northern Freegold Resour...
      LSE
      MRC
      Mercantile Investment
      Delayed Upgrade Clock